Exploring the benefits, harms and costs of genomic newborn screening for rare diseases

Emma L Baple, Richard H Scott, Siddharth Banka, James Buchanan, Louise Fish, Sarah Wynn, Dominic Wilkinson, Sian Ellard, Daniel G MacArthur, Zornitza Stark

Research output: Contribution to journalCommentary/debatepeer-review

Abstract

The prospect of genomic screening in newborns attracts both hype and criticism, but carefully designed, large-scale, prospective research studies are the only way to generate the data needed for its rigorous evaluation.

Original languageEnglish
Pages (from-to)1823-1825
Number of pages3
JournalNature Medicine
Volume30
Issue number7
Early online date19 Jun 2024
DOIs
Publication statusPublished - 1 Jul 2024

Keywords

  • Cost-Benefit Analysis
  • Genetic Testing/economics
  • Genomics/economics
  • Humans
  • Infant, Newborn
  • Neonatal Screening/economics
  • Rare Diseases/genetics

Fingerprint

Dive into the research topics of 'Exploring the benefits, harms and costs of genomic newborn screening for rare diseases'. Together they form a unique fingerprint.

Cite this